Literature DB >> 24504078

World Gastroenterology Organisation global guidelines: diagnosis, management and prevention of hepatitis C April 2013.

Muhammed Umar1, Aamir G Khan, Zaigham Abbas, Sanjeev Arora, Naqvi Asifabbas, Andre Elewaut, Gamal Esmat, Graham Foster, Michael Fried, Khean-L Goh, Tul Bushra Khaar Hamama, Michio Imawari, Vasily Isakov, Justus Krabshuis, Douglas LaBrecque, Anton Lemair, Peter Malfertheiner, Steve Ryder, Peter Schiedermaier, Davor Stimac, Rakesh Tandon, Federico Villamil, Rodrigo Zapata, Peter Ferenci.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24504078     DOI： 10.1097/MCG.0000000000000050

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN： 0192-0790            Impact factor:   3.062


× No keyword cloud information.
  4 in total

1.  Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia.

Authors:  Vasily Isakov; Igor Nikitin; Vladimir Chulanov; Pavel Ogurtsov; Ekaterina Lukyanova; Jianmin Long; Janice Wahl; Frans A Helmond
Journal:  World J Hepatol       Date:  2016-02-28

2.  Revolution in the diagnosis and management of hepatitis C virus infection in current era.

Authors:  Farina M Hanif; Zain Majid; Nasir Hassan Luck; Abbas Ali Tasneem; Syed Muddasir Laeeq; Muhammed Mubarak
Journal:  World J Hepatol       Date:  2022-04-27

3.  Cost-effectiveness analysis of sofosbuvir compared to current standard treatment in Swiss patients with chronic hepatitis C.

Authors:  Alena M Pfeil; Oliver Reich; Ines M Guerra; Sandrine Cure; Francesco Negro; Beat Müllhaupt; Daniel Lavanchy; Matthias Schwenkglenks
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

4.  Non-invasive prediction model for high-risk esophageal varices in the Chinese population.

Authors:  Long-Bao Yang; Jing-Yuan Xu; Xin-Xing Tantai; Hong Li; Cai-Lan Xiao; Cai-Feng Yang; Huan Zhang; Lei Dong; Gang Zhao
Journal:  World J Gastroenterol       Date:  2020-06-07       Impact factor: 5.742
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.